What is the latest price of Pfizer’s new drug talazoparib?

Talazoparib, a new type of PARP inhibitor developed by Pfizer, provides a new treatment option for breast and prostate cancer patients. It effectively inhibits the growth and spread of tumor cells by blocking DNA repair mechanisms, bringing hope to patients. The original drug Talazoparib produced by Pfizer has won the recognition of doctors and patients with its unique efficacy and safety.

However, in terms of selling price, the price of the original drug of talazoparib is relatively high. Currently, there are two main specifications on the market, namely0.25mg*30 capsules and 1mg*30 capsules. Among them, the packaging specification of 0.25mg*30 pills is priced at more than 10,000 yuan per box, while the packaging specification of 1mg*30 pills is nearly 50,000 yuan. For many patients, such prices undoubtedly increase the financial pressure of treatment.

Faced with the high prices of original drugs, some patients have begun to pay attention to the choice of generic drugs. Among them, the price of the generic version of talazoparib produced by Laos Element Pharmaceuticals is relatively affordable, with a box of 1mg*30 pills priced at about 4,000 yuan. Such a price is undoubtedly an affordable treatment option for many patients with greater financial pressure.

However, when patients choose drugs, in addition to price factors, they also need to consider the quality and efficacy of the drug. Whether it is original medicine or generic medicine, it should be used under the guidance of a doctor. Patients need to take the medicine on time and in the right amount, and undergo regular physical examinations to ensure the efficacy and safety of the medicine.

In short, talazoparib, as a newPARP inhibitor, provides a new treatment option for patients with breast and prostate cancer. Although the original drug is more expensive, patients can choose the appropriate version according to their own conditions. No matter which drug is chosen, it should be used under the guidance of a doctor to ensure the safety and effectiveness of the treatment.